A new model of care for familial hypercholesterolaemia: what is the role of cardiology?
Familial hypercholesterolaemia (FH) is a co-dominantly inherited disorder that causes marked elevation in plasma cholesterol and premature coronary heart disease. There are at least 45,000 people with FH in Australia and New Zealand, but most remain undiagnosed and undertreated. To bridge this gap in coronary prevention the FH Australasia Network has developed a model of care for FH. We present the executive summary, with a commentary contrasting the recommendations with other international guidelines and highlighting the role of the cardiologist.
Lipid Disorders Clinic, Metabolic Research Centre, Department of Internal Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia. gerald.watts@uwa.edu.au
Gerald F
GF
Watts
David R
DR
Sullivan
Frank M
FM
van Bockxmeer
Nicola
N
Poplawski
Ian
I
Hamilton-Craig
Peter M
PM
Clifton
Richard C
RC
O'Brien
Warrick
W
Bishop
Peter M
PM
George
Christopher
C
Semsarian
Andrew
A
Tonkin
D001315:Australia; D002309:Cardiology; D002784:Cholesterol / Q000097:blood; D002793:Cholic Acids / Q000097:blood; D003327:Coronary Disease / Q000097:blood / Q000209:etiology / Q000628:therapy*; D006801:Humans; D009520:New Zealand; D017410:Practice Guidelines as Topic; D043202:Steroid Metabolism, Inborn Errors / Q000097:blood / Q000150:complications / Q000628:therapy*
D002793:Cholic Acids; D002784:Cholesterol